NPPA Caps Trade Margins on 137 Anti-Cancer Drugs at 30% | Prices May Fall by Up to 70% |

The National Pharmaceutical Pricing Authority (NPPA) has notified Trade Margin Rationalisation (TMR) for 137 non-scheduled anti-cancer medicines to help make cancer treatment more affordable.

Question: What price-control measure was notified by the NPPA for 137 anti-cancer medicines?

Answer: Trade Margin Rationalisation (TMR), with trade margins capped at 30% of the Maximum Retail Price (MRP), excluding GST. The measure is expected to reduce prices by up to 70%, depending on existing price structures. Revised prices are scheduled to take effect from 9 November 2026.

📚 Useful for UPSC, SSC, Banking, Railway and other competitive examinations.

Follow Current Affairs Studio for daily current affairs, important government policies and exam-focused GK quizzes.

#NPPA #AntiCancerDrugs #CurrentAffairs2026 #GovernmentSchemes #CurrentAffairsStudio

NPPA anti cancer drugs, 137 anti cancer medicines, trade margin rationalisation, TMR, NPPA 30 percent trade margin cap, cancer drug prices India, anti cancer drug price control, medicine price reduction, prices may fall by 70 percent, National Pharmaceutical Pricing Authority, Department of Pharmaceuticals, Drugs Prices Control Order 2013, health current affairs 2026, Indian government policies, current affairs October 2026, daily current affairs, GK quiz, UPSC current affairs, SSC GK, banking awareness, railway exam preparation, competitive exams, Current Affairs Studio